SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-043760
Filing Date
2021-08-19
Accepted
2021-08-18 21:32:08
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_celularity.htm   iXBRL 10-Q 529386
2 CERTIFICATION f10q0621ex31-1_celularity.htm EX-31.1 12531
3 CERTIFICATION f10q0621ex31-2_celularity.htm EX-31.2 12600
4 CERTIFICATION f10q0621ex32-1_celularity.htm EX-32.1 4602
5 CERTIFICATION f10q0621ex32-2_celularity.htm EX-32.2 4699
  Complete submission text file 0001213900-21-043760.txt   3268355

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celu-20210630.xsd EX-101.SCH 41867
7 XBRL CALCULATION FILE celu-20210630_cal.xml EX-101.CAL 20989
8 XBRL DEFINITION FILE celu-20210630_def.xml EX-101.DEF 187322
9 XBRL LABEL FILE celu-20210630_lab.xml EX-101.LAB 317407
10 XBRL PRESENTATION FILE celu-20210630_pre.xml EX-101.PRE 188650
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_celularity_htm.xml XML 362453
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 211188259
SIC: 2834 Pharmaceutical Preparations